- Migraines With Aura Associated With Increased Risk For Cardiovascular Disease By : Medical News
Women age 45 years or older who experience migraines with aura (associated neurologic symptoms such as temporary visual disturbances) are at a higher risk for heart attack, ischemic stroke, angina and death due to ischemic cardiovascular disease compared to women who do not report a migraine history, according to a study in the July 19 issue of JAMA. In contrast, migraine without aura, the most common form of migraine, was not associated with increased risk of any cardiovascular event. - Women With Certain Types Of Migraines Have Higher Risk Of Heart Disease By : Medical News
Women who have migraines with visual problems have increased risk for heart disease, according to a study published on Wednesday in the Journal of the American Medical Association, Long Island Newsday reports. - Revealed: Inflammatory Processes In Arteriosclerosis By : Medical News
Revolutionary new results concerning substances that play major roles in the inflammatory response have been published in the American scientific journal PNAS in two articles from Karolinska Institutet. Inflammation is important in, for example, cardiovascular disease. The results open the way for the development of new drugs both for prevention and for treatment. - All Men With ED Should Be Monitored For Heart And Vascular Disease Say Researchers By : Medical News
An Italian study of men with erectile dysfunction and coronary artery disease (CAD) has shown for the first time that the rates of dysfunction differ according to the type and severity of the disease. - Blood Test Predicts Sickle Cell Disease Complication, Identifies Patients At High Risk Of Death By : Medical News
A team of scientists with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has found that a hormone detected in a simple blood test can identify patients with sickle cell disease who have developed a life-threatening complication called pulmonary hypertension. The team has also found that the same hormone is a clear predictor of death in adult sickle cell patients. - Heart Has Enough Oxygen To Survive Hypothermia, CPR Crucial By : Medical News
Researchers from Norway may have ruled out insufficient oxygen supply to the heart as the critical variable in whether a mammal's heart survives while in a hypothermic state. - Oral Rehydration Works As Well As Intravenous Rehydration For Diarrhoea By : Medical News
In wealthy countries it is fashionable to prefer intravenous therapy (IVT) over oral rehydration therapy (ORT). A Cochrane Review however, shows that ORT is just as effective as IVT. - Some Spinal Cord Patients May Benefit From Aggressive Heart Pacing By : Medical News
Patients with recurring problems with the heart slowing or stopping after a neck injury damages their cervical spinal cord may need aggressive therapy to avoid further cardiovascular problems and even death, Medical College of Georgia researchers say. - Heart Damage From Some Cancer Drugs Worsens Over The Years Study Indicates By : Medical News
It is well documented that some anti-cancer drugs can damage the heart, but a long-term follow-up of children and young adults who had doxorubicin [1] treatment for bone tumours suggests that the damage gets progressively worse as the years go on. - Gene Mutation That Leads To "Broken Hearts" Found By UT Southwestern Researchers By : Medical News
Researchers at UT Southwestern Medical Center have identified a group of fruit fly gene mutations responsible for "broken hearts" in the embryonic stages of development, a discovery that could help identify genes that cause human heart defects. - Long-term Ibuprofen Regimen After Brain Injury Worsens Cognition In Animal Study By : Medical News
Researchers at the University of Pennsylvania School of Medicine found that chronic ibuprofen therapy given after brain injury worsens cognitive abilities. These findings - in a preliminary, animal-model study - have important implications for traumatic brain injury (TBI) patients who are often prescribed such nonsteroidal anti-inflammatory drugs (NSAIDS) as ibuprofen for chronic pain. The findings appear online this month in Experimental Neurology. - OLYMPIA Phase I Registry Demonstrates Efficacy Of TAXUS(R) Liberte(TM) Stent System In Complex By : Medical News
Boston Scientific Corporation (NYSE: BSX) today announced preliminary six-month results from Phase I of its global OLYMPIA registry, supporting the safety and efficacy of the TAXUS(R) Liberte(TM) coronary stent system(1) in real-world patients. The results were announced at the SOLACI (Sociedad Latino Americana de Cardiologia Intervencionista) Congress in Porto Alegre, Brazil. - Abbott Receives FDA Clearance For I-STAT(R) BNP Test To Diagnose Congestive Heart Failure By : Medical News
Abbott (NYSE: ABT) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its i-STAT(R) BNP cartridge, a new point of care diagnostic test used to quickly assess the level of BNP (brain naturietic peptide) in patients in emergency rooms, heart failure clinics and observation units, laboratories and other critical care settings. - Grueling Four-day Race Becomes Stanford Lab For Cardiac Experiments By : Medical News
Stanford cardiologist Euan Ashley wanted to study the hearts of endurance athletes, so he set up a mobile heart lab at the finishing line of the ultra-endurance race "Adrenalin Rush" in the Scottish Highlands and waited for the racers to come in. - Study Examines Usefulness Of Cardiac CT Scan For Detecting Blockages In Coronary Arteries By : Medical News
Use of the 16-row multidetector computed tomography (CT) scan to detect narrowing of coronary arteries may result in a high number of cases in which the diagnosis cannot be determined, limiting the clinical usefulness of the test, according to a study in the July 26 issue of JAMA. However, the heart CT test may be useful in excluding coronary disease in selected patients. - Boston Globe Examines Concerns Over Heart Disease Guidelines Published In Paid Supplement To Medical By : Medical News
The Boston Globe on Tuesday examined controversy over heart disease detection guidelines published recently in a paid supplement to the American Journal of Cardiology. The guidelines recommend that all men ages 45 to 75 and women ages 55 to 75 receive screenings -- as well as follow-up tests years later -- to detect calcium deposits in blood vessels and measure blood flow to the brain. The recommendations, if followed nationwide, would affect 50 million people and cost more than $25 billion. - Study Suggests CYPHER(R) Sirolimus-Eluting Coronary Stent More Cost-Effective Than The Taxus Stent By : Medical News
The CYPHER(R) Sirolimus-eluting Coronary Stent is more cost-effective than the Taxus Stent for treating patients at high risk of artery re-blockage, according to a German study published in the July 18 issue of the Journal of the American College of Cardiology. The study found that use of the CYPHER(R) Stent was associated with similar in-hospital costs but significantly lower total costs at 9 to 12 months compared to Taxus. - Digitalis Safe In Patients With Common Form Of Heart Failure, Study Shows By : Medical News
Despite a widely held belief that the heart drug digitalis shouldn't be given to patients with diastolic heart failure, a new analysis shows it is relatively safe. - Carotid Stenting Reduces Symptoms Of Depression By : Medical News
Inserting a stent to open a narrowed carotid artery has been found to reduce symptoms of depression that may be associated with carotid stenosis, according to a study in the August issue of Radiology. - Carotid Artery Stenting Deemed Safe Treatment Option For Elderly In Recent Study By : Medical News
Carotid artery stenting can be performed safely in patients 80 years or older, according to study results released for the first time today at the 3rd Annual American Society of Interventional & Therapeutic Neuroradiology (ASITN) Course & Workshops in Rio Grande, Puerto Rico. - WorldHeart Announces Five Years Of Novacor LVAS Support In A US Recipient By : Medical News
World Heart Corporation (Nasdaq: WHRT, TSX: WHT) (WorldHeart), a global technology leader in mechanical circulatory support systems, announced today that a US patient entered his sixth year of continuous support on his original Novacor(R) Left Ventricular Assist System (LVAS). - Sports Legend Terry Francona Urges Americans To Understand The Signs, Symptoms And Risk Factors By : Medical News
Boston Red Sox manager, Terry Francona, spent his entire life devoted to baseball. In 2004, leading his team to the victory championship was a dream come true in more ways than one. After suffering from a pulmonary embolism (PE), a complication of deep-vein thrombosis (DVT), Terry is lucky to be alive. Today, he is devoting his time to another dream: reducing the risk of DVT. - New Wireless-Enabled Devices Extending The Reach Of Cardiovascular Care By : Medical News
As new-generation cardiac devices and monitoring products converge with wireless networks, medical professionals are acquiring the capability to monitor key patient parameters and implanted device data in near-real time. These new communication-enabled devices function like On-Stars for humans, sending data on a timed or exception basis. - Nanotechnology Enables Low-dose Treatment Of Atherosclerotic Plaques By : Medical News
In laboratory tests, one very low dose of a drug was enough to show an effect on notoriously tenacious artery-clogging plaques. What kind of drug is that potent? - Momenta Pharmaceuticals Files Investigational New Drug Application For Novel Anticoagulant By : Medical News
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that it has submitted an electronic Investigational New Drug (IND) application to the U.S. Food and Drug Administration to begin a Phase I human clinical study of M118, the Company's lead novel development candidate. M118 is an anticoagulant designed specifically to treat acute coronary syndromes (ACS). - Pigeons Provide Clue To Solving Common Problem In Heart Patients By : Medical News
Through studying pigeons with genetic heart disease, researchers at Wake Forest University School of Medicine have discovered a clue about why some patients' heart vessels are prone to close back up after angioplasty. - Improved Gene Therapy Method For Hereditary Heart Conditions Tested By UF Scientists By : Medical News
A new way of delivering corrective genes with a single injection into a vein holds promise for long-lasting treatments of hereditary diseases of the heart, University of Florida researchers report. - Doctors Remove Clots With A Corkscrew By : Medical News
Dr. Pierre Gobin and Dr. Dana Leifer are studying whether MRI (magnetic resonance imaging), in an emergency setting, can help determine if ischemic stroke patients would benefit from intervention with a device known as the MERCI Retriever. The MERCI Retriever is a tiny corkscrew-like device that can be threaded through the circulatory system and into an artery near the surface of the brain to ensnare and remove a clot.
( - Research Into Early Detection Of Life-Threatening Embolisms Using MRI By : Medical News
Dr. Jonathan Weinsaft of Weill Medical College of Cornell University has been awarded a Doris Duke Charitable Foundation Grant, one of only 11 bestowed this year. The $400,000 award will support research into new imaging techniques to detect heart blood clots in patients recovering from heart attacks. - The Combined Impact Of Obesity, Diabetes, And Cardiovascular Disease Is The World's Biggest By : Medical News
Leading clinicians, medical organizations, and the 2006 Cardiometabolic Health Congress will convene to discuss and debate state-of-the-art therapies to prevent type 2 diabetes and reduce cardiovascular risk in the growing number of patients at increased cardiometabolic risk. The congress will take place October 19-21, 2006 at the Marriott Copley Place in Boston, M.A. and will attract practicing endocrinology, cardiology and primary care clinicians throughout North America. - Tufts Researchers Find That Omega-3's Can Reduce Risk Of Cardiovascular Disease By : Medical News
A comprehensive review of published clinical studies by research associates at Tufts-New England Medical Center has found that increased consumption of DHA* and EPA** (omega-3's), "reduces the rates of all-cause mortality, cardiac and sudden death, and possibly stroke." - American College Of Cardiology/American Heart Association/European Society Of Cardiology Scientific By : Medical News
Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation released today by the American College of Cardiology, American Heart Association and the European Society of Cardiology. - Revised ACC/AHA/ESC Guidelines On Atrial Fibrillation Recommend New Approach: Stroke Risk By : Medical News
Risk factors for stroke should be used to determine whether anti-clotting therapy is given to people with an irregular heartbeat called atrial fibrillation (AF), according to revised Guidelines for the Management of Patients with Atrial Fibrillation released today by the American College of Cardiology, American Heart Association and the European Society of Cardiology. - Robotic Surgery Techniques Used In Cardiac Cell Therapy Research By U Of MN By : Medical News
Researchers at the University of Minnesota were successful in using robotic surgery to deliver stem cell treatment to damaged heart tissue in pigs. - When Should Cardiac Arrest Patients Be Resuscitated Outside Hospital? By : Medical News
Canadian researchers have devised guidelines aimed at helping EMTs (emergency medical technicians) decide when to halt resuscitation procedures for cardiac arrest patients outside hospital. - Stress Imaging Tests Predict Prognosis Of Heart Disease In Obese Persons By : Medical News
Researchers identified an accurate method that may detect whether obese individuals have a low, intermediate or high risk of coronary artery disease, the leading cause of death in the United States, notes a report in the August issue of the Journal of Nuclear Medicine. - How Young Is Your Heart? World Heart Day, Sunday September 24th 2006 By : Medical News
A calorie restricted, nutritionally balanced diet has been associated with slowing the ageing process of the heart - which is why this year's World Heart Day campaign asks: “How Young is Your Heart?” - TandemHeart(R) PTVA(R) System From CardiacAssist Used In Nation's Top-Ranked Hospitals By : Medical News
The TandemHeart(R) PTVA(R) System from CardiacAssist, the world's only extracorporeal 5.0 lpm circulatory support system, is used in 17 of the top 20 heart and heart surgery hospitals in the U.S. and 11 of the nation's top 14 hospitals overall, based on 2006 rankings recently released by U.S. News & World Report. The hospital ranking is included in the magazine's 17th annual guide to America's best hospitals. - Older Age A Risk Factor For Brain Hemorrhage In Patients Both On & Off Common Blood Thinner Therapy By : Medical News
Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain whether or not they are using a common blood thinning therapy, according to a new study. - Important Notice To All Bjork-Shiley Convexo-Concave Heart Valve Implantees By : Medical News
Because of a risk of strut fracture that could result in death or serious injury, all Bjork-Shiley Convexo-Concave Heart Valves (BSCC) were removed from the market by the manufacturer. Approximately 86,000 of these heart valves were implanted in patients worldwide. Under a class action settlement agreement in the Bowling, et al. v. Pfizer Inc., et al. heart valve litigation, financial benefits are still available to certain patients implanted with the BSCC heart valve. - FoxHollow Technologies To Participate In Canaccord Adams Summer Seminar By : Medical News
FoxHollow Technologies (Nasdaq: FOXH), which manufactures and markets the SilverHawk(TM) Plaque Excision System, a minimally invasive device for the treatment of peripheral artery disease (PAD), is scheduled to participate in the 26th Annual Canaccord Adams Summer Seminar on Wednesday, August 9, 2006, in Boston, Massachusetts. - High Blood Pressure Induces Low Fat Metabolism In Heart Muscle By : Medical News
"The heart is the single most energy-consuming organ per weight in the body," says Lisa de las Fuentes, M.D.
Under some conditions this energy-hungry organ is prone to defects in its energy metabolism that contribute to heart disease, according to research published in a recent issue of the Journal of Nuclear Cardiology by de las Fuentes and colleagues at Washington University School of Medicine in St. Louis. - CVD Patients Should Be Tested For Chronic Kidney Disease By : Medical News
Cardiovascular disease (CVD) patients and those at risk for CVD should consider getting blood and urine tests that can detect chronic kidney disease (CKD), according to a new American Heart Association Science Advisory. - Micell Technologies And Pacific Northwest National Laboratory Expand Research Collaboration By : Medical News
Micell Technologies announced an expansion of its license agreement for using supercritical fluids for creating medical device surface modifications with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle. Under the expansion of the agreement, research will focus on additional applications of the award winning e-RESS technology for creating drug-eluting coatings for cardiovascular stents. - New Explanation For The Cause Of Atherosclerosis: The Acidity Theory By : Medical News
Recent findings were reported by a team of scientists at the University of California, San Diego, linking mechanical forces with structural and biochemical changes in blood vessel cells that could explain why atherosclerotic lesions form preferentially at branches of coronary arteries. The study from Roland Kaunas and colleagues was published online in Cellular Signalling on February 28, 2006 and will appear in the journal's October 2006 issue. - Making Heart Surgery Intervention Safer By : Medical News
Eureka project E 2654 Viacortis has developed new techniques to monitor the viability of heart tissue during heart surgery, so that cardiac surgeons have a real-time, comprehensive indication of how the heart is reacting. - CardioTech Signs Agreement With Principle Investigator For CardioPass(TM) European Clinical Trial By : Medical News
CardioTech International, Inc. (Amex: CTE), a developer and manufacturer of innovative medical devices, today reported that it has signed an agreement with a Principle Investigator for the European clinical trial of its CardioPass(TM) synthetic coronary artery bypass graft. - Bayer Diagnostics Expands Availability Of High Sensitivity And High Precision Troponin Assay By : Medical News
Bayer HealthCare, Diagnostics Division, a member of the Bayer Group (NYSE: BAY), announced today the availability of its new Tnl-Ultra(TM) Troponin assay on ADVIA Centaur(R) CP Immunoassay system. The launch of the TnI-Ultra assay on ADVIA Centaur CP provides additional options for high sensitivity troponin testing on Bayer's immunoassay systems. ADVIA Centaur CP TnI-Ultra assay is an addition to ADVIA Centaur and ADVIA IMS TnI-Ultra assays released earlier this year. - Antibody Binding To Heart Muscle Cells Disrupts The Beating Heart By : Medical News
Congenital heart block (CHB) is a condition in which the transfer of electrical nerve impulses that regulate the rhythmic pumping of heart muscle is altered. Although CHB is strongly associated with the transfer, via the placenta, from mother to fetus of antibodies to the ribonucleoproteins SSA/Ro and/or SSB/La, the precise role of these antibodies in CHB was not previously known. - New Tools To Help Pinpoint Treatments For Heart Failure Devised By Researchers By : Medical News
Scientists studying heart cells have devised a new way to visualize and quantify the rise and fall in the activity of a key enzyme linked to heart failure, offering them a window to the inner workings of heart cells that is expected to help in the development of more effective drugs to treat heart failure. - Boosting The ‘Good' Cholesterol, High-Density Lipoprotein (HDL) By : Medical News
When it comes to cholesterol, most of us worry about too much of the “bad” kind, low-density lipoprotein (LDL). It causes plaque to build up in and potentially block the arteries that supply your heart with blood. - Heart Failure Drugs May Be Beneficial For Patients With Hardening Of The Arteries By : Medical News
Drugs currently used to treat heart failure should be considered for all patients with hardening of the arteries (atherosclerosis), according to an Article in this week's issue of The Lancet. The study suggests that ACE (angiotensin-converting enzyme) inhibitors may reduce the number of serious circulatory problems, such as heart attack and stroke, in patients with atherosclerosis. - Do You Want to Know Antidote to Depression? By : Vanshika Anand
Today we are living in highly competitive world. We dream to have everything big. Big house, big car, big bank balance, big friendly circle and so on. - Signalife, World Renown Professional Athletes, Partner For Wellness And Athletic Dominance By : Medical News
Signalife, Inc. ("Company"), (Amex: SGN) announced that it has initiated its cardiovascular wellness and athletic program. The first engagement will be the most demanding i.e. testing and utilization with worldwide track and field athletes as well as nationwide fitness facilities. Through this program the parties intend to explore protocols for the utilization of Signalife's revolutionary product. - Swedish Medical Center In Seattle Enters Heart-Surgery Affiliation With Cleveland Clinic By : Medical News
Swedish Medical Center and Cleveland Clinic -- an international leader and the top-ranked heart center in America according to U.S. News and World Report -- today announced a clinical affiliation in cardiac surgery that will further enhance heart care offered by the Seattle medical center. This is the first affiliation Cleveland Clinic has established with another cardiac-surgery program on the West Coast. - Abbott Enrolls First Patient In New Clinical Trial Of XIENCE(TM) V Drug Eluting Stent By : Medical News
Abbott (NYSE: ABT) announced today enrollment of the first patient in its SPIRIT IV clinical trial for the continued evaluation of the safety and efficacy of the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in a more complex patient population. - Nurses Next Line Of Defense For Heart Patients When The Doctor Is Out By : Medical News
According to a landmark study by researchers at Mount Sinai School of Medicine, heart failure (HF) patients who received routine follow-up by a nurse in addition to visits to a physician had fewer hospitalizations and functioned better than patients who received only usual care. The study appears in the August 15, 2006 issue of the Annals of Internal Medicine. - British Heart Foundation Announces New Round Of Research Investment In Dundee By : Medical News
The British Heart Foundation (BHF) has announced a new raft of research grants worth almost £900,000 to scientists across Scotland.
Among those winning awards are researchers from the University of Dundee. - NMT Medical Voluntarily Withdraws CardioSEAL(R) PFO HDE And Receives FDA Approval For New STARFlex By : Cardiology News
NMT Medical, Inc. (Nasdaq: NMTI), an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat cardiac sources of migraine headaches. - FDA Approves New Indication For PLAVIX(R) (clopidogrel Bisulfate) Offering New Option For Patients By : Cardiology News
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for the antiplatelet agent PLAVIX(R) (clopidogrel bisulfate) to reduce the rate of death from any cause and the rate of a combined endpoint of re-infarction, stroke or death in patients with acute ST-segment elevation myocardial infarction (STEMI). - British Heart Foundation Announces Latest Research Investment At Surrey By : Cardiology News
The British Heart Foundation (BHF) has announced a new raft of research grants worth £5.3 million to scientists across the UK. Among those winning awards are researchers from University of Surrey. Dr Jian-Mei Li and Professor Susanna Hourani received £143,547 to investigate an abundant chemical in our bodies, called adenosine, which can cause changes in the diameter of our smallest blood vessels in tissues, which can in turn cause a change in our blood pressure. - Abbott Enrolls First Patient In New Clinical Trial Utilizing XIENCE™ V Drug Eluting Stent By : Cardiology News
Abbott announced today enrollment of the first patient in its SPIRIT IV clinical trial for the continued evaluation of the safety and efficacy of the XIENCE™ V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in a more complex patient population. - FDA Approves New Indication For Plavix® (clopidogrel Bisulfate) Offering New Option For Patients By : Cardiology News
Sanofi-aventis and Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for the antiplatelet agent PLAVIX® (clopidogrel bisulfate) to reduce the rate of death from any cause and the rate of a combined endpoint of re-infarction, stroke or death in patients with acute ST-segment elevation myocardial infarction (STEMI). - Medication May Promote Opening Of Arteries Following Stroke By : Cardiology News
A medication known as argatroban, when combined with another drug already used in the treatment of stroke patients, may help restore the flow of blood through blocked arteries, according to a preliminary study in the August issue of Archives of Neurology, one of the JAMA/Archives journals. - Neglected Disease That Causes Heart Failure Should Be Addressed By : Cardiology News
The international research community needs to focus more attention on Chagas' disease - an infectious disease that kills 50 000 people a year, states an Editorial in this week's special cardiology issue of The Lancet.
Chagas' disease, prevalent in Latin America, is caused by infection with the parasite Trypanosoma cruzi. An estimated 18 million people are chronically infected with the parasite and about 100 million are at risk of infection in 21 countries in Latin America. - Identifying A New Genetic Component Of Heart Disease By : Cardiology News
Two independent papers in the September 1 issue of G&D reveal a critical role for the ILK protein in regulating cardiac contractility - identifying a new genetic component of heart disease. - Always The Gentleman: CaMKII Opens The Door For Calcium To Enter By : Cardiology News
Aldosterone has recently been identified as a pathogenic stimulus of heart failure. It is produced by cells of the adrenal gland if their intracellular Ca2+ concentration is elevated, such as occurs after stimulation with angiotensin II. - Moving Biotechnology Closer To Replacing Electronic Pacemakers By : Cardiology News
UC Davis researchers have successfully used a custom designed protein and gene delivery system to restore normal heart rhythms in pigs with electronic pacemakers, reducing their dependence on implanted devices. This work suggests that scientists are one step closer to making bioengineering a reality in treating the more than 2.2 million Americans affected by irregular heartbeats. - FDA Approves New Medical Use For Plavix - Drug Benefits Patients With Common Form Of Heart Attack By : Cardiology News
The Food and Drug Administration (FDA) on 17 August approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty). - Wiley Acquires Clinical Cardiology and Scanning Journals By : Health News
John Wiley & Sons, Inc., announced today that it has acquired publishing assets from the Clinical Cardiology Publishing Company (CCPC) and the Foundation for Advances in Medicine and Science (FAMS). Wiley will assume publishing for two peer-reviewed journals, Clinical Cardiology: An Indexed and Peer-Reviewed Journal for Advances in the Treatment of Cardiovascular Disease and SCANNING, The Journal of Scanning Microscopies. - Medtronic Launches Unique Annuloplasty Ring for Dynamic Repair of the Heart's Mitral Valve By : Health News
Medtronic, Inc. (NYSE:MDT) today announced worldwide introduction of the new and unique Medtronic CG Future(R) COMPOSITE Annuloplasty Ring used by heart surgeons to repair - rather than replace - a mitral valve that is narrowed or leaking. The new CG Future COMPOSITE Ring is the industry's first annuloplasty product providing both semi-rigid posterior remodeling and fully flexible anterior support, thereby allowing physiologic movement throughout the cardiac cycle. - U.S. Food And Drug Administration Grants Expanded Indication For The NaviStar(R) ThermoCool(R) By : Cardiology News
The U.S. Food and Drug Administration (FDA) has granted an expanded indication to the first automated ablation system supporting an open-loop irrigated catheter. The NaviStar(R) ThermoCool(R) Catheter is now available for the treatment of adults with specific rapid heartbeats, who have already experienced failure with other treatments such as device or other antiarrythmic drug therapy. - Favourable Phase 2a Pharmacokinetic And Safety Data For Glypromate(R) Confirmed By : Cardiology News
Neuren Pharmaceuticals (ASX: NEU) has today announced the detailed pharmacokinetics analysis of the Phase 2 clinical trial of its lead compound, Glypromate(R), for the reduction of cognitive decline following cardiac surgery. - Treating Chest Pain In The Average Woman Tops $1 Million Over Lifetime By : Cardiology News
Treating chest pain associated with coronary artery disease (CAD) could cost a woman more than $1 million during her lifetime; and even the chest pain associated with mild artery blockage (nonobstructive CAD) could reach $750,000 for an average woman, according to a study published in Circulation. - About.com Launches Podcast Series Focused on Heartburn, Acid Reflux By : Health News
About.com has launched a six-part podcast series to educate consumers on how to cope with heartburn and acid reflux disease. The series, sponsored by AstraZeneca, is featured at http://heartburnpodcast.about.com/. It will provide listeners with in-depth knowledge on topics such as: What Causes Heartburn; Acid Reflux and Your Diet; How to Talk to Your Doctor about Acid Reflux; Exercising with Acid Reflux; and How Stress Affects Your Acid Reflux. - Cytokinetics Announces Initiation Of Phase I Clinical Trial For Oral Administration Of CK-1827452 By : Cardiology News
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the initiation of a Phase I clinical trial evaluating the pharmacokinetic profile of CK-1827452 when administered orally to healthy volunteers. CK-1827452 is a direct cardiac myosin activator under evaluation as a potential treatment for patients with acute and chronic heart failure. - New Guidelines For Ventricular Arrhythmias And Sudden Cardiac Death, Consensus Reached By : Cardiology News
The 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (SCD) were released today by the American College of Cardiology (ACC), American Heart Association (AHA), and the European Society of Cardiology (ESC) in collaboration with the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS). - Occasional Cup Of Coffee May Trigger Heart Attack By : Cardiology News
For some people, an occasional cup of coffee could be more conducive to bringing on a heart attack than drinking the java regularly, say researchers from Brown University and Harvard School of Public Health, USA. The scientists found that for some people, a cup of coffee can make them have a heart attack within an hour of consuming it. - Injury During Ablation For Atrial Fibrillation May Be Prevented By Imaging Technique By : Cardiology News
A new imaging procedure may reduce the risk of esophageal injury in patients undergoing catheter ablation for atrial fibrillation (AF), according to a study published in the September 2006 edition of Heart Rhythm. Researchers used intracardiac echocardiography (ICE) to provide real-time imaging of the esophagus to gauge the power, temperature and duration of the ablation, and to monitor the development of lesions and other potential complications that may result from ablation. - President Gerald Ford Underwent Successful Angioplasty By : Cardiology News
Former US President Gerald Ford underwent an angioplasty procedure to treat a blockage in two of his arteries. Stents were inserted to increase blood flow through those arteries, according to a press release by his office. The procedure took place at the Mayo Clinic yesterday. - Largest Review To Date Of Loeys-Dietz Syndrome By : Cardiology News
At least three severe, potentially fatal genetic diseases leave patients with aortas so flimsy that they can rupture in pregnancy and labor or even lesser activities, often without warning. Beta blockers, curbing exercise, proactive blood vessel surgery and other approaches can be helpful, but their usefulness varies according to which disease and when they're offered. - Post-Traumatic Stress Disorder Can Afflict Those Battling Heart Disease By : Cardiology News
Post-traumatic stress disorder (PTSD) isn't limited to soldiers or witnesses of a horrifying event. It can also appear after a heart attack, a stroke, or heart surgery. Not only does PTSD cause emotional and psychological distress, it may also slow recovery and hasten the progression of heart disease, reports the August issue of the Harvard Heart Letter. - Study Suggests TV-watching Lowers Physical Activity By : Cardiology News
A study of low-income housing residents has documented that the more television people say they watched, the less active they were, researchers from Dana-Farber Cancer Institute and colleagues report. - Valve Disease Study Suggests New Public Health Concern By : Cardiology News
Research from Mayo Clinic estimates that about 5 million adult Americans have moderate or severe heart valve disease as a consequence of aging, according to a Mayo Clinic study published online in The Lancet. - Exercise Deadly If You Have Irregular Heartbeat By : Cardiology News
The results of a study in mice that was conducted by researchers from Vanderbilt University has provided a potential explanation for why the heartbeat of humans lacking the protein cardiac calsequestrin (CASQ2) is irregular, and potentially fatal, only during exercise and not at other times. - Arteriogenesis And Angiogenesis: New Tricks For BMX By : Cardiology News
The symptoms of coronary artery disease and peripheral arterial disease are caused by decreased blood flow, which is known as ischemia, to the heart muscles and/or other tissues, respectively. This in turn triggers local expansion of the lumen of blood vessels (arteriogenesis) and the growth of new blood vessels (angiogenesis), which together allow blood flow to the damaged tissue to be restored. - No Time To Work Out? Follow These Tips For A Ten Minute Workout By : Cardiology News
No time to exercise? No excuse! Phil Tyne, director of the Baylor Tom Landry Fitness Center in Dallas, says anyone can fit in 10 minutes a day, alternating cardiovascular one day and strength training the next. Always talk to your doctor before beginning any exercise plan. - No Time To Work Out? Follow These Tips For A Ten Minute Workout By : Cardiology News
No time to exercise? No excuse! Phil Tyne, director of the Baylor Tom Landry Fitness Center in Dallas, says anyone can fit in 10 minutes a day, alternating cardiovascular one day and strength training the next. Always talk to your doctor before beginning any exercise plan. - Gene Variants Reveal Susceptibility To Cardiovascular Disease By : Cardiology News
Variations in a gene that acts as a switch to turn on other genes may predispose individuals to heart disease, an international team of researchers led by Duke University Medical Center scientists has discovered. - Heart Disease Patients Have Arteries 40 Years Older Than Their Real Age By : Cardiology News
Scientists from Cambridge University, UK, have found that people with advanced heart disease have arteries with the DNA damage of people 40 years older. In other words, the arteries of a patient with advanced heart disease are biologically 40 years older than the patient. The scientists found evidence of telomere damage in the smooth muscle cells of diseased blood vessels. - African-Americans Have Same Risk As Pack-a-Day Smokers For Developing Peripheral Arterial Disease By : Cardiology News
September first is the kickoff day for the Legs For Life(R) free national screening program for the early detection of peripheral arterial disease (PAD) to prevent amputation, heart attack and stroke. Although 10 million Americans have PAD, African-Americans are twice as likely to develop it. Their increased risk makes them as vulnerable as someone who has smoked a pack of cigarettes a day for 20 years. - Life-saving Surgery For Heart Patients Increases By More Than A Third, USA By : Cardiology News
Use of a surgical procedure to open plaque-narrowed or blocked arteries in hospital patients - called percutaneous coronary angioplasty, or PTCA -- increased from 581,000 to 791,000 between 1997 and 2004, according to HHS' Agency for Healthcare Research and Quality. - Abbott Announces Completion Of Enrollment In Groundbreaking Vulnerable Plaque Study By : Cardiology News
Abbott today announced completion of enrollment in a landmark study designed to increase clinical understanding of "vulnerable" plaque -- a lipid-rich coronary plaque that suddenly ruptures -- believed to be the cause of most heart attacks. The study enrolled 700 acute coronary syndrome patients receiving stents in the United States and Europe. Patients will be followed up for at least two, and up to five, years. - Safety & Efficacy Record Of TAXUS(R) Drug-Eluting Stent Systems Reinforced By : Cardiology News
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European Society of Cardiology/World Congress of Cardiology 2006, which runs from September 2 to 6 in Barcelona, Spain. - Traditional Therapies Can Prevent Heart Disease Too By : Ng Peng Hock
In the ancient era, people used herbs or plants to cure those who were sick, although they could not possibly identify the sickness they encountered at that time. - Individual Physician Judgment Best When It Comes To Treating Chronic Coronary Artery Disease By : Cardiology News
Medication, angioplasty or surgery? For some heart disease patients, there's no clear-cut choice. The key to getting the best care is to follow your individual doctor's advice, new research shows. - World's Largest Drug-Eluting Stent Registry Reaches Halfway Point In Enrollment By : Cardiology News
Boston Scientific Corporation (NYSE: BSX) announced today that enrollment has exceeded 13,000 patients in the TAXUS OLYMPIA registry, designed to evaluate the safety and performance of the Company's second-generation drug-eluting coronary stent (DES), TAXUS(R) Liberte(TM)(1), in a real-world setting. OLYMPIA is the world's largest DES registry and plans to enroll up to 27,000 patients treated for complex coronary lesions, at more than 500 centers worldwide. - Cordis STEER-IT™ Deflecting Tip Guidewire Now Available In The USA, Europe And Canada By : Cardiology News
Cordis Corporation announced today its STEER-IT™ Deflecting Tip Guidewire is now available for commercial use in the United States, Canada and Europe. The innovative product will be available in other parts of the world soon. - Sister, Can You Spare A Million? Study Says Chest Pain Toll In Women Is More Than Physical By : Cardiology News
Considering both direct and indirect costs, the financial burden on a woman who has chest pain and blocked coronary arteries may total more than $1 million during her lifetime. But even a woman who suffers from angina without an obstruction can expect her condition to take a toll in the neighborhood of $800,000, according to a report in the Aug. 29 issue of Circulation. - Sister, Can You Spare A Million? Study Says Chest Pain Toll In Women Is More Than Physical By : Cardiology News
Considering both direct and indirect costs, the financial burden on a woman who has chest pain and blocked coronary arteries may total more than $1 million during her lifetime. But even a woman who suffers from angina without an obstruction can expect her condition to take a toll in the neighborhood of $800,000, according to a report in the Aug. 29 issue of Circulation.
|
